Market Place
Sourcing Support
Pharma companies may feel heat of US tariffs on China
15 Apr 2025 //
ECONOMICTIMES
Sanofi`s Respiratory Pipeline Advances with New Asthma Data
15 Apr 2025 //
PRESS RELEASE
Sanofi India MD Rodolfo Hrosz to step down on April 30
11 Apr 2025 //
INDPHARMAPOST
Tolebrutinib phase 3 data in NEJM show benefit in MS disability
08 Apr 2025 //
PRESS RELEASE
Rilzabrutinib granted orphan drug designation in US for 2 diseases
04 Apr 2025 //
PRESS RELEASE
Sanofi pays Nurix $15M upfront for autoimmune degrader
03 Apr 2025 //
PRESS RELEASE
Sanofi poaches GSK’s head of development for R&D bet
01 Apr 2025 //
ENDPTS
US FDA approves Sanofi`s bleeding disorder therapy
29 Mar 2025 //
PRESS RELEASE
Sanofi`s mRNA vaccine for chlamydia gains USFDA fast track
28 Mar 2025 //
EXPRESSPHARMA
Dupixent approved as first biologic for COPD in Japan
28 Mar 2025 //
GLOBENEWSWIRE
Chlamydia vaccine candidate granted fast track designation by FDA
26 Mar 2025 //
GLOBENEWSWIRE
Tolebrutinib Submission Accepted In US For Multiple Sclerosis
25 Mar 2025 //
PRESS RELEASE
Availability of the Q1 2025 Aide mémoire
24 Mar 2025 //
PRESS RELEASE
Sanofi to acquire Dren Bio`s immunology unit
20 Mar 2025 //
PRESS RELEASE
Sanofi adopts FDA flu strains for 2025-26 season
14 Mar 2025 //
PR NEWSWIRE
Dupixent Shows Late-Breaking Ph3 Data In Bullous Pemphigoid
08 Mar 2025 //
PRESS RELEASE
Sanofi prices EUR 1.5 billion bond issue
05 Mar 2025 //
PRESS RELEASE
Sanofi India declares 8% growth in net sales for Q4-2024
01 Mar 2025 //
PRESS RELEASE
Novavax Sees Royalties, Lower Costs From Sanofi COVID Deal
27 Feb 2025 //
REUTERS
Sanofi passes $125M ILT2 asset back to Biond Biologics
27 Feb 2025 //
FIERCE BIOTECH
Enveda Secures Sanofi Backing, Series C To $150M For AI Discovery
26 Feb 2025 //
BUSINESSWIRE
Sarclisa Approved In Japan For Newly Diagnosed Multiple Myeloma
25 Feb 2025 //
GLOBENEWSWIRE
Teva & Sanofi present new outcome from Phase 2b study of duvakitug
25 Feb 2025 //
PRESS RELEASE
Sanofi and CD&R sign Opella share purchase agreement
19 Feb 2025 //
PRESS RELEASE
FDA Accepts sBLA for Dupilumab for bullous pemphigoid
19 Feb 2025 //
PRESS RELEASE
Sanofi gains FDA nod for first biosimilar version of NovoLog
19 Feb 2025 //
FIERCE PHARMA
Dupixent sBLA Gets FDA Priority Review For Bullous Pemphigoid
18 Feb 2025 //
GLOBENEWSWIRE
Sanofi`s Biologic Merilog Solostar Receives Approval in US
14 Feb 2025 //
FDA
Sanofi`s Biologic Merilog Receives Approval in US
14 Feb 2025 //
FDA
Sanofi takes $250M hit after J&J E. coli vaccine fails in ph. 3
14 Feb 2025 //
PRESS RELEASE
Filing Of 2024 US Form 20-F & French Financial Report Announced
13 Feb 2025 //
GLOBENEWSWIRE
Sanofi launches Rezurock against chronic Graft-versus-host disease
10 Feb 2025 //
BIOSPECTRUM
Execution of a share buyback agreement for up to €2 billion
08 Feb 2025 //
PRESS RELEASE
Novo fails trial, linking obesity asset to psychiatric effects
06 Feb 2025 //
FIERCE BIOTECH
Mitem Acquires FLISINT Specialty From Sanofi for Rare Diseases
04 Feb 2025 //
BUSINESSWIRE
Sanofi announces buy back of shares from L’Oréal
03 Feb 2025 //
PRESS RELEASE
Q4 sale growth of 10.3%, 2024 business EPS guidance exceeded
31 Jan 2025 //
PRESS RELEASE
Sanofi plans share buybacks, signals more deals post Opella sale
30 Jan 2025 //
REUTERS
Information concerning total number of voting rights & shares
29 Jan 2025 //
GLOBENEWSWIRE
Novo to cap insulin prices in settlement; joins Lilly, Sanofi
28 Jan 2025 //
REUTERS
Sarclisa Approved In EU As 1st Anti-CD38 For Multiple Myeloma
22 Jan 2025 //
PRESS RELEASE
Opella reaches study milestone for Cialis
21 Jan 2025 //
PRESS RELEASE
Sanofi Updates November Voting Rights And Share Information
15 Jan 2025 //
GLOBENEWSWIRE
CEOs encourage `transparency` amid US anti-vaccine push
14 Jan 2025 //
FIERCE PHARMA
Sarclisa Gets First Approval In China For Relapsed Myeloma
13 Jan 2025 //
PRESS RELEASE
Scribe Therapeutics Hits Milestone in Sanofi Collaboration
13 Jan 2025 //
BUSINESSWIRE
Sarclisa Subcutaneous Meets Endpoints In Iraklia Phase 3 Study
09 Jan 2025 //
PRESS RELEASE
Sanofi`s subQ version of Sarclisa measures up to its IV version
09 Jan 2025 //
PRESS RELEASE
LB Pharma`s twist on old Sanofi drug passes schizophrenia test
09 Jan 2025 //
FIERCE BIOTECH
Sanofi partners with Alloy Therapeutics to make new CNS drug
08 Jan 2025 //
PRESS RELEASE
I-Mab pauses Sanofi-partnered to make play for busy CLDN18.2
07 Jan 2025 //
FIERCE BIOTECH
Genzyme`s Biologic Lumizyme Receives Suppl Approval in US
30 Dec 2024 //
FDA
Sanofi initiates Ph 3 for PCV21 & expand Collab with SK bioscience
26 Dec 2024 //
PRESS RELEASE
Sanofi pays SK $52M as children`s pneumococcal shot enters Ph 3
24 Dec 2024 //
FIERCE PHARMA
Sanofi scoops up China rights to Cytokinetics’ heart disease med
20 Dec 2024 //
FIERCE BIOTECH
Cytokinetics Announces Sanofi Acquired Aficamten Rights in China
20 Dec 2024 //
GLOBENEWSWIRE
Jean-Paul Kress to join Sanofi`s Board of Directors
19 Dec 2024 //
GLOBENEWSWIRE
New treatments needed in chronic hand eczema
19 Dec 2024 //
FIERCE PHARMA
Genzyme`s Biologic Cerezyme Receives Suppl Approval in US
19 Dec 2024 //
FDA
Teva, Sanofi say bowel disease drug met primary targets
18 Dec 2024 //
PRESS RELEASE
